BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28074552)

  • 1. Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.
    Faluyi OO; Eng L; Qiu X; Che J; Zhang Q; Cheng D; Ying N; Tse A; Kuang Q; Dodbiba L; Renouf DJ; Marsh S; Savas S; Mackay HJ; Knox JJ; Darling GE; Wong RK; Xu W; Azad AK; Liu G
    Cancer Med; 2017 Feb; 6(2):361-373. PubMed ID: 28074552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
    Eng L; Azad AK; Qiu X; Kong QQ; Cheng D; Ying N; Tse A; Kuang Q; Dodbiba L; Renouf DJ; Marsh S; Savas S; Mackay HJ; Knox JJ; Darling GE; Wong RK; Xu W; Liu G; Faluyi OO
    Carcinogenesis; 2015 Sep; 36(9):956-62. PubMed ID: 26014353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome.
    Korpanty GJ; Eng L; Qiu X; Faluyi OO; Renouf DJ; Cheng D; Patel D; Chen Z; Tse BC; Knox JJ; Dodbiba L; Teichman J; Azad AK; Wong R; Darling G; Reisman D; Cuffe S; Liu G; Xu W
    Oncotarget; 2017 Apr; 8(17):28093-28100. PubMed ID: 28427211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.
    Feber A; Xi L; Pennathur A; Gooding WE; Bandla S; Wu M; Luketich JD; Godfrey TE; Litle VR
    Ann Thorac Surg; 2011 May; 91(5):1523-30. PubMed ID: 21420070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
    Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
    Xue J; Jia E; Ren N; Xin H
    Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma.
    Xie Y; Diao L; Zhang L; Liu C; Xu Z; Liu S
    Gene; 2014 Apr; 539(2):198-202. PubMed ID: 24530479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of common genetic variants in pre-microRNA in susceptibility and prognosis of esophageal cancer.
    Umar M; Upadhyay R; Prakash G; Kumar S; Ghoshal UC; Mittal B
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E10-8. PubMed ID: 22692992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
    Cescon DW; Bradbury PA; Asomaning K; Hopkins J; Zhai R; Zhou W; Wang Z; Kulke M; Su L; Ma C; Xu W; Marshall AL; Heist RS; Wain JC; Lynch TJ; Christiani DC; Liu G
    Clin Cancer Res; 2009 May; 15(9):3103-9. PubMed ID: 19383811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations.
    Zhang J; Huang X; Xiao J; Yang Y; Zhou Y; Wang X; Liu Q; Yang J; Wang M; Qiu L; Zheng Y; Zhang P; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M
    PLoS One; 2014; 9(6):e100055. PubMed ID: 24945256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation.
    de Larrea CF; Navarro A; Tejero R; Tovar N; Díaz T; Cibeira MT; Rosiñol L; Ferrer G; Rovira M; Rozman M; Monzó M; Bladé J
    Clin Cancer Res; 2012 Jul; 18(13):3697-704. PubMed ID: 22539802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of microRNA machinery genes predict overall survival of esophageal squamous carcinoma.
    Wang C; Dong H; Fan H; Wu J; Wang G
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 29226993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
    Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
    Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
    Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
    Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
    Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
    J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing.
    Chiam K; Mayne GC; Watson DI; Woodman RJ; Bright TF; Michael MZ; Karapetis CS; Irvine T; Phillips WA; Hummel R; Wang T; Pimlott LK; Marri S; Astill DS; Ruszkiewicz AR; Thompson SK; Hussey DJ
    Ann Surg Oncol; 2018 Sep; 25(9):2731-2738. PubMed ID: 29987600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of microRNA polymorphisms in patients with advanced esophageal squamous cell carcinoma receiving platinum-based chemotherapy.
    Wu C; Li M; Hu C; Duan H
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):335-41. PubMed ID: 24288122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population.
    Yin J; Wang X; Zheng L; Shi Y; Wang L; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
    PLoS One; 2013; 8(11):e80570. PubMed ID: 24260422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.
    Buas MF; Onstad L; Levine DM; Risch HA; Chow WH; Liu G; Fitzgerald RC; Bernstein L; Ye W; Bird NC; Romero Y; Casson AG; Corley DA; Shaheen NJ; Wu AH; Gammon MD; Reid BJ; Hardie LJ; Peters U; Whiteman DC; Vaughan TL
    PLoS One; 2015; 10(6):e0128617. PubMed ID: 26039359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.